New Gene Mutations Identified that Promote Prostate Cancer

Share this content:

the Cancer Therapy Advisor take:

According to a new global study published in the journal Nature Genetics, researchers have identified 23 genes that are associated with an increased risk for developing prostate cancer. In the study, researchers analyzed over 10 million genetic biomarkers in 80,000 men with prostate cancer. They found 23 genes linked with prostate cancer in addition to the 76 previously identified.

In addition, the researchers found that these genetic mutations are associated with 33% of the heritable risk of prostate cancer. They also observed a 5.7-fold increased risk for developing prostate cancer in the top 1% of men with these genetic mutations compared with those from the average population.

Of the 23 gene mutations identified, some were specific to African populations, which commonly develop the aggressive form of prostate cancer. Furthermore, 15 of the 23 new genes identified were in men with European ancestry while 7 were observed in multi-ethnic populations.

Researchers say they did not identify any genes associated with the aggressive form of prostate cancer, but hope to locate them in the next sample of 100,000 men with prostate cancer. The researchers want to better understand how these genetic mutations work together to increase the risk for developing cancer.

Paradigm Shift: There's More to Tumor Drug Resistance Than Just Gene Mutations
Researchers have identified 23 genes associated with increased risk for developing prostate cancer.
A global study of 80,000 men with prostate cancer has identified another 23 prostate cancer risk loci Scientists could soon better predict a man's risk of getting prostate cancer after a worldwide team of researchers carried out the largest-ever analysis of the cancer's genetic biomarkers, reported in Nature Genetics today.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs